MiRNA-21, miRNA-10b, and miRNA-34a Expression in Canine Mammary Gland Neoplasms

1. Boggs R.M., Moody J.A., Long C.R., Tsai K.L., Murphy K.E.: Identification, amplification and characterization of miR-17-92 from canine tissue. Gene 2007, 404, 25-30.10.1016/j.gene.2007.08.01517904311Search in Google Scholar

2. Boggs R.M, Wright Z.M, Stickney M.J., Porter W.W., Murphy K. E. MicroRNA expression in canine mammary cancer. Mamm Genome 2008, 19, 561-569.10.1007/s00335-008-9128-718665421Search in Google Scholar

3. Calin G.A., Liu C.G., Sevignani C., Ferracin M., Felli N., Dumitru C.D., Shimizu M., Cimmino A., Zupo S., Dono M., Dell’Aquila M.L., Alder H., Rassenti L., Kipps T.J., Bullrich F., Negrini M., Croce C.M.: MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci USA 2004, 101, 11755-11760.10.1073/pnas.040443210151104815284443Search in Google Scholar

4. Von Deetzen C., Schmeck B.T., Gruber A.D., Klopfleisch R.: Malignancy associated microRNA expression changes in canine mammary cancer of different malignancies. ISRN Vet Sci 2014:148597. doi: 10.1155/2014/148597.10.1155/2014/148597406055425002976Search in Google Scholar

5. Fenger J.M., Bear M.D., Volina S., Tzu-Yin L., Harrington B.K., London C.A., Kisseberth W.C.: Overexpression of miR-9 in mast cells is associated with invasive behavior and spontaneous metastasis. BMC Cancer 2014, 14-84.10.1186/1471-2407-14-84393348124517413Search in Google Scholar

6. Genini S., Guziewicz K.E., Beltran W.A., Aguirre G.D.: Altered miRNA expression in canine retinas during normal development and in models of retinal degeneration. BMC Genomics 2014, 15, 172.10.1186/1471-2164-15-172402913324581223Search in Google Scholar

7. Lewis B.P, Burge C.B., Bartel D.P.: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120, 15-20.10.1016/j.cell.2004.12.03515652477Search in Google Scholar

8. Li L., Yuan L., Luo J., Gao J., Guo J., Xie X.: Mi-R34a inhibits proliferation and migration of breast cancer through down-regulation of Bcl-2 and SIRT1. Clin Exp Med 2013, 13, 109-117.10.1007/s10238-012-0186-522623155Search in Google Scholar

9. Lu J., Getz G., Miska E.A., Alvarez-Saavedra E., Lamb J., Peck D., Sweet-Cordero A., Ebert B.L., Mak R.H., Ferrando A.A., Downing J.R., Jacks T., Horvitz H.R., Golub T.R.: MicroRNA expression profiles classify human cancers. Nature. 2005, 435, 834-838.Search in Google Scholar

10. Ma L., Teruya-Feldstein J., Weinberg R.A.: Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007, 449, 682-688.10.1038/nature0617417898713Search in Google Scholar

11. Miller T.E., Ghoshal K., Ramaswamy B., Roy S., Datta J., Shapiro C.L., Jacob S., Majumder S.: MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1. J Biol Chem 2008, 283, 29897-29903.10.1074/jbc.M804612200257306318708351Search in Google Scholar

12. Min H., Yoon S.: Got target? Computational methods for microRNA target prediction and their extension. Exp Mol Med 2010, 42, 233-244.10.3858/emm.2010.42.4.032285932320177143Search in Google Scholar

13. Noguchi S., Mori T., Hoshino Y., Yamada N., Nakagawa T., Sasaki N., Akao Y., Maruo K.: Comparative study of anti-oncogenic microRNA-145 in canine and human malignant melanoma. J Vet Med Sci 2012, 74, 1 -8.10.1292/jvms.11-026421836381Search in Google Scholar

14. O’Day E., Lal A.: MicroRNAs and their target gene networks in breast cancer. Breast Cancer Res Treat 2010, 12, 201.10.1186/bcr2484287955920346098Search in Google Scholar

15. Ortholan C., Puissegur M.P., Ilie M., Barbry P., Mari B., Hofman P.: MicroRNAs and lung cancer: new oncogenes and tumour supressors, new prognosis factors and potential therapeutic targets. Curr Med Chem 2009, 16, 1047-1061.10.2174/09298670978758183319275611Search in Google Scholar

16. Peres-Rivas L.G., Jerez J.M., Carmona R., de Luque V., Vicioso L., Claros M.G., Viguera E., Pajares B., Sanchez A., Ribelles N., Alba E., Lozano J.: A microRNA signature associated with early recurrence in breast cancer. PLoS One 2014, 9, e91884.10.1371/journal.pone.0091884395483524632820Search in Google Scholar

17. Porkka K.P., Pfeiffer M.J., Waltering K.K., Vessella R.L., Tammela T.L., Visakorpi T.: MicroRNA expression profiling in prostate cancer. Cancer Res 2007, 67, 6130-6135.10.1158/0008-5472.CAN-07-053317616669Search in Google Scholar

18. Shi M., Liu D., Duan H., Shen B., Guo N.: Metastasis-related miRNAs, active players in breast cancer invasion and metastasis. Cancer Metastasis Rev 2010, 29, 785-799.10.1007/s10555-010-9265-920938719Search in Google Scholar

19. Tavazoie S.F., Alarcon C., Oskarsson T., Padua D., Wang Q., Bos P.D., Gerald W.L., Massaque J.: Endogenous human microRNAs that supress breast cancer metastasis. Nature 2008, 451, 147-152.10.1038/nature06487278249118185580Search in Google Scholar

20. Uhl E., Krimer P., Schliekelman P., Tampkins S.M., Suter S.: Identification of altered microRNA expression in canine lymphoid cell lines and cases of B- and T- cell lymphomas. Genes Chromosomes Cancer 2011, 50, 950-967.10.1002/gcc.2091721910161Search in Google Scholar

21. Valastyan S., Reinhardt F., Benaich N., Caloqrias D., Szasz A.M., Wang Z.C., Brock J.E., Richardson A.L., Weinberg R.A.: A pleyotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 2009, 137, 1032-1046.10.1016/j.cell.2009.03.047276660919524507Search in Google Scholar

22. Vinall R.L, Kent M.S, deVere White R.W.: Expression of microRNAs in urinary bladder samples obtained from dogs with grossly normal bladders, inflammatory bladder disease, ortransitional cell carcinoma. Am J Vet Res 2012, 73, 1626-1633.10.2460/ajvr.73.10.162623013190Search in Google Scholar

23. Volina S., Calin G.A., Liu C.G., Ambs S., Cimmino A., Petrocca F., Visone R., Iorio M., Roldo C., Ferracin M., Prueitt R.L., Yanaihara N., Lanza G., Scarpa A., Vecchione A., Negrini M., Harris C.C., Croce C.M.: A microRNA expression signature of human solid tumours defines cancer gene targets. Proc Natl Acad Sci USA 2006, 103, 2257-2261.10.1073/pnas.0510565103141371816461460Search in Google Scholar

24. Wang Z., Liao H., Deng Z., Yang P., Du N., Zhanng Y., Ren H.: miRNA-205 affects infiltration and metastasis of breast cancer. Biochem Biophys Res Commun 2013, 441, 139-143.10.1016/j.bbrc.2013.10.02524129185Search in Google Scholar

25. Winter J., Diedrich S.: MicroRNA Biogenesis and cancer. Meth Mol Biol 2011, 676, 3-22.10.1007/978-1-60761-863-8_120931386Search in Google Scholar

26. Yan L.X., Huang X.F., Shao Q., Huang M.Y., Deng L., Wu Q.L., Zeng Y.X., Shao J.Y.: MicroRNA miR-21 overexpression in human breast cancer is associated with advancer clinical stage, lymph node metastasis and patient poor prognosis. RNA 2008, 14, 2348-2360.10.1261/rna.1034808257886518812439Search in Google Scholar

27. Yang S., Li Y., Zhang T., Li S., Luo A., Chen H., Ding F., Wang X., Liu Z.: MicroRNA-34 supresses breast cancer invasion and metastasis by directly targeting Fra-1. Oncogene. 2012, 32, 4294-4303.Search in Google Scholar

28. Yu F., Yao H., Zhu P., Zhang X., Pan Q., Gong C., Huang Y., Hu X., Su F., Lieberman J., Song E.: Let-7 regulates self-renewal and tumourigenicity of breast cancer cells. Cell 2007, 131, 1109-1123.10.1016/j.cell.2007.10.05418083101Search in Google Scholar

29. Yu Z., Baserga R., Chen L., Wang C., Lisanti M.P., Pestell R.G.: MicroRNA, cell cycle, and human breast cancer. Am J Pathol 2010, 176, 1058-1064.10.2353/ajpath.2010.090664283212520075198Search in Google Scholar

30. Zhang B., Pan X., Cobb G.P., Anderson T.A.: MicroRNAs as oncogenes and tumour suppressors. Dev Biol 2007, 302, 1 -12.10.1016/j.ydbio.2006.08.02816989803Search in Google Scholar